Glycolipid acceptor specificity of a human Gal beta(1-3/1-4) GlcNAc alpha 2,3-sialyltransferase. 1995

D Miyamoto, and S Takashima, and T Suzuki, and T Nishi, and K Sasaki, and Y Morishita, and Y Suzuki
Department of Biochemistry, University of Shizuoka, School of Pharmaceutical Science, Japan.

A human Gal beta(1-3/1-4)GlcNAc alpha 2,3-sialyltransferase, called ST-4, is a sialyltransferase involved in the in vivo biosynthesis of sialyl Lewis X (NeuNAc alpha 2-3Gal beta 1-4(Fuc alpha 1-3)GlcNAc) determinant. The ST-4 enzyme could utilize nLc4Cer (Gal beta 1-4GlcNAc beta 1-3Gal beta 1-4Glc beta 1-1'Cer) containing type 2 sugar chain, Lc4Cer (Gal beta 1-3GlcNAc beta 1-3Gal beta 1-4Glc beta 1-1'Cer) containing type 1 sugar chain, Gg4Cer (Gal beta 1-3GalNAc beta 1-3Gal beta 1-4Glc beta 1-1'Cer), and LacCer as glycolipid acceptor substrates, but not other neutral glycolipids (GalCer, GlcCer, Gb3Cer, Gg3Cer, Gb4Cer) and gangliosides (GM1a, GM2, GM3, GD1a, GD1b, and GT1b) as substrates. The order of sialic acid incorporation into glycolipids for the enzyme was nLc4Cer > Gg4Cer > Lc4Cer > LacCer. The apparent Km values of ST-4 for nLc4Cer and Gg4Cer were 0.47 and 2.5 mM, respectively. Thus, the ST-4 could efficiently utilize both nLc4Cer and Gg4Cer as glycolipid acceptor substrates in vitro, suggesting that the substrate specificity of the enzyme may be similar to that of a glycolipid sialyltransferase (SAT-3), which is defined as the enzyme that uses both nLc4Cer and Gg4Cer as glycolipid acceptor substrates.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007983 Lewis Blood Group Antigens Carbohydrate antigens structurally related to the ABH BLOOD-GROUP SYSTEM. They may occur as a modification of saccharide chains on glycolipids or glycoproteins on cell surfaces or in plasma, or as free oligosaccharides in secretions. Lewis antigens are not synthesized in blood cells. Instead Lewis glycolipids present in plasma are absorbed onto the surface of ERYTHROCYTES; LYMPHOCYTES; and PLATELETS. The phenotypes Le(a) and Le(b) are the result of the actions of two genes the Le gene (fucosyltransferase FUT3) and the Se gene (fucosyltransferase FUT2) on the precursor carbohydrate, glycolipid or glycoprotein. Other FUCOSYLTRANSFERASES can also synthesize the Lewis antigens. Blood Group Lewis Related Antigens,Lewis Antigen Related Tumor-Associated Antigens,Lewis Antigens,Lewis Blood Group Related Antigens,Lewis Blood Group Related Tumor-Associated Antigens,Lewis Blood-Group System,Lewis Related Antigens,Lewis System,Sialyl Lewis Antigens,Le Antigens,Le(a) Blood Group System,Antigens, Lewis,Antigens, Lewis Related,Antigens, Sialyl Lewis,Blood-Group System, Lewis,Lewis Antigen Related Tumor Associated Antigens,Lewis Blood Group Related Tumor Associated Antigens,Lewis Blood Group System
D009844 Oligosaccharides Carbohydrates consisting of between two (DISACCHARIDES) and ten MONOSACCHARIDES connected by either an alpha- or beta-glycosidic link. They are found throughout nature in both the free and bound form. Oligosaccharide
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006017 Glycolipids Any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol (see GLYCERIDES), a sphingoid, a ceramide (CERAMIDES) (N-acylsphingoid) or a prenyl phosphate. (From IUPAC's webpage) Glycolipid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000080506 Sialyl Lewis X Antigen A sialylated version of Lewis X antigen expressed on cell surfaces. It is a ligand for SELECTINS. 5-Acetylneuraminyl-(2-3)-Galactosyl-(1-4)-(Fucopyranosyl-(1-3))-N-Acetylglucosamine,CD15s Antigen,Sialyl Le(x),Sialyl Lewis X,Sialyl Lewis(x) Antigen,Sialyl Lewis(x) Tetrasaccharide,Sialyl SSEA-1,Sialyl Stage-Specific Embryonic Antigen-1,Sialyl-Lex,Sialylated Lewis X Antigen,NAG-1,4-F-1,3-GN,Neu5Ac-2-3-Gal-1-4-(Fuc-1-3)-GlcNAc,NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAc-R,SLe(x),SLe(x)-OS,alpha-Neu5Ac-(2-3)-beta-D-Gal-(1-4)-(alpha-L-Fuc-(1-3))-beta-D-GlcNAc,Antigen, CD15s,Lewis X, Sialyl,Sialyl Lex,Sialyl SSEA 1,Sialyl Stage Specific Embryonic Antigen 1
D000094663 beta-Galactoside alpha-2,3-Sialyltransferase Sialyltransferases that catalyze the transfer of N-ACETYLNEURAMINIC ACID from CYTIDINE MONOPHOSPHATE N-ACETYLNEURAMINIC ACID to the 3-OH of the GALACTOSE residue of N-GLYCANS. Asialofetuin Sialyltransferase,CMP N-Acetylneuraminate-beta-Galactoside alpha-2,3-Sialyltransferase,CMP-ANGS-Transferase,CMP-Acetylneuraminate-Galactoside (alpha 2-3)-Sialyltransferase,CMP-Neu5Ac-GAl beta1-3GalNAc alpha-2,3-Sialyltransferase,CMP-Neu5Ac-Gal1-3GalNAc alpha-2,3-Sialyltransferase,CMP-NeuAc-Galactoside (alpha 2-3)-Sialyltransferase,CMPSialic Acid beta-Galactosyl-1-3-N-Acetylgalactosaminide alpha 2-3-Sialyltransferase,Gal beta1,3GalNAc alpha2,3-Sialyltransferase,alpha 2-3-Sialyltransferase,beta-D-Galactoside 3-alpha-Sialyltransferase,ST3Gal I,ST3Gal II,ST3Gal III,ST3Gal IV,ST3Gal VI,alpha-2,3-ST(O),2-3-Sialyltransferase, alpha,3-alpha-Sialyltransferase, beta-D-Galactoside,CMP ANGS Transferase,CMP N Acetylneuraminate beta Galactoside alpha 2,3 Sialyltransferase,CMP Neu5Ac GAl beta1 3GalNAc alpha 2,3 Sialyltransferase,CMP Neu5Ac Gal1 3GalNAc alpha 2,3 Sialyltransferase,CMPSialic Acid beta Galactosyl 1 3 N Acetylgalactosaminide alpha 2 3 Sialyltransferase,N-Acetylneuraminate-beta-Galactoside alpha-2,3-Sialyltransferase, CMP,Sialyltransferase, Asialofetuin,alpha 2 3 Sialyltransferase,alpha-2,3-Sialyltransferase, CMP N-Acetylneuraminate-beta-Galactoside,alpha-2,3-Sialyltransferase, CMP-Neu5Ac-GAl beta1-3GalNAc,alpha-2,3-Sialyltransferase, CMP-Neu5Ac-Gal1-3GalNAc,alpha-2,3-Sialyltransferase, beta-Galactoside,beta D Galactoside 3 alpha Sialyltransferase,beta Galactoside alpha 2,3 Sialyltransferase,beta1-3GalNAc alpha-2,3-Sialyltransferase, CMP-Neu5Ac-GAl
D012799 Sialyltransferases A group of enzymes with the general activity CMP-N-acetylneuraminate:acceptor N-acetylneuraminyl transferase. They catalyze the transfer of N-ACETYLNEURAMINIC ACID from CMP-N-ACETYLNEURAMINIC ACID to an acceptor, which is usually the terminal sugar residue of an oligosaccharide, a glycoprotein, or a glycolipid. Glycoprotein Sialyltransferases,Glycosyltransferase Family 29,Sialyltransferase,Ectosialyltransferase,Glycoprotein Sialyltransferase,Sialyltransferase, Glycoprotein,Sialyltransferases, Glycoprotein

Related Publications

D Miyamoto, and S Takashima, and T Suzuki, and T Nishi, and K Sasaki, and Y Morishita, and Y Suzuki
July 1993, The Journal of biological chemistry,
D Miyamoto, and S Takashima, and T Suzuki, and T Nishi, and K Sasaki, and Y Morishita, and Y Suzuki
July 1993, Biochemical and biophysical research communications,
D Miyamoto, and S Takashima, and T Suzuki, and T Nishi, and K Sasaki, and Y Morishita, and Y Suzuki
October 1993, The Journal of biological chemistry,
D Miyamoto, and S Takashima, and T Suzuki, and T Nishi, and K Sasaki, and Y Morishita, and Y Suzuki
November 1982, The Journal of biological chemistry,
D Miyamoto, and S Takashima, and T Suzuki, and T Nishi, and K Sasaki, and Y Morishita, and Y Suzuki
July 2003, Sheng li ke xue jin zhan [Progress in physiology],
D Miyamoto, and S Takashima, and T Suzuki, and T Nishi, and K Sasaki, and Y Morishita, and Y Suzuki
February 1995, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology,
D Miyamoto, and S Takashima, and T Suzuki, and T Nishi, and K Sasaki, and Y Morishita, and Y Suzuki
December 1995, Carbohydrate research,
D Miyamoto, and S Takashima, and T Suzuki, and T Nishi, and K Sasaki, and Y Morishita, and Y Suzuki
October 1992, The Journal of biological chemistry,
D Miyamoto, and S Takashima, and T Suzuki, and T Nishi, and K Sasaki, and Y Morishita, and Y Suzuki
January 1994, Methods in enzymology,
Copied contents to your clipboard!